Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Olga, Anagnostou"'
Autor:
Olga Anagnostou, Katerina Micha, George Tsitsanis, Argyro Karakosta, Georgia Papadopoulou, Eleni Panopoulou, Christos Danopoulos, Charikleia Tsatsaroni, Nikolaos Avgerinos
Publikováno v:
Population Medicine. 5
Autor:
Olga Anagnostou, Evangelia Koutli, Sofia Vasileiadi, Spilios Manolakopoulos, Hariklia Kranidioti, Paris Pantsas, Kanellos Rafail Koustenis, Pinelopi Antonakaki, Melanie Deutsch
Publikováno v:
Annals of Gastroenterology
Background Direct-acting antivirals (DAAs) offer high cure rates in people who inject drugs (PWID) with hepatitis C virus (HCV) infection. There are concerns regarding lower response rates among PWID in real life. We evaluated the outcome of DAA ther
Autor:
M. Malliori, E. Kokolesis, Angelos Hatzakis, I. Detsi, G. Kalamitsis, V. Sypsa, Olga Anagnostou, Sotiris Roussos
Publikováno v:
Europe PubMed Central
The European Journal of Public Health
The European Journal of Public Health
Background The first case of SARS-CoV-2 in Greece was identified in February 2020. During the COVID-19 pandemic two lockdowns took place (March-May 2020/November 2020-ongoing). People who use drugs (PWUD), as well as the homeless, constitute vulnerab
Autor:
George V. Papatheodoridis, Anastasios Fotiou, Olga Anagnostou, Angelos Hatzakis, George Kalamitsis, Argiro Antaraki, Ilias Gountas, Dimitrios Paraskevis, Vana Sypsa
Publikováno v:
Journal of Viral Hepatitis. 26:1311-1317
People who inject drugs (PWID) comprise one of the major transmission risk groups for human immunodeficiency virus (HIV) and hepatitis C virus (HCV). In 2011, Athens experienced a large HIV outbreak among PWID. Significant public health interventions
Autor:
John Goulis, Olga Anagnostou, Christos Tsoulas, Vana Sypsa, Ioannis S. Elefsiniotis, George V. Papatheodoridis, Angelos Hatzakis, Spilios Manolakopoulos, Christos Lionis, George N. Dalekos
Publikováno v:
Annals of Gastroenterology
There are estimated to be 74,000-134,000 patients living with chronic hepatitis C in Greece, but only 20-30% of them are aware of their disease status. In July 2017, the Hellenic National Plan for Hepatitis C was announced in alignment with the World
Autor:
Theofilos Rosenberg, George Rachiotis, Vana Sypsa, George V. Papatheodoridis, Apostolos Vantarakis, Agis Terzidis, Ioanna Petraki, Maria Kantzanou, Magda Gavana, Niki Maria Voudouri, Giota Touloumi, Argiro Karakosta, Olga Anagnostou, Angelos Hatzakis
Publikováno v:
JMIR Research Protocols
BackgroundAlthough infectious diseases are globally on the decline, they remain a major global public health problem. Among them, the hepatitis B virus (HBV) or hepatitis C virus (HCV) and HIV infection are of primary interest. Valid prevalence data
Autor:
Ndumbi, Patricia, del Romero, J., Pulido, F., Velasco Arribas, M., Dronda, F., Blanco Ramos, J. Ramón, García de Olalla, P., Ocaña, I., Belda-Ibañez, J., del Amo, J., Álvarez-del Arco, D., Gennotte, Anne-Françoise, Barthélemy, C. cile La Morté, Wengenroth, Claudia, Touloumi, Giota, Ilias, Gountas, Loumpiana, Koulai, Olga, Anagnostou, Schüttfort, Gundolf, Wenganroth, Claudia, Barros, Henrique, Meireles, Paula, del Amo, Julia, Álvarez, D. bora, Monge, Susana, Ledergerber, Bruno, Staehelin, Cornelia, Prins, Maria, Bill, Janneke, Zuure, Freke, Prestileo, Tullio, Petrosillo, Nicolla, Burns, Fiona, Fakoya, Ibi, del Romero J, Jorge, Rodríguez, Carmen, Vera, Mar, Río, Isabel, Paredes, Vanessa, Sanz, Nieves, Dronda, Fernando, Arribas, María Velasco, Mateo, María Gracia, Gutiérrez, Mar, Domingo, Pere, Knobel, Hernando, Pellicer, Teresa, Fernández, Emma, del Carmen Ligero, María, Robau, Margarita, Miró, José María, Ocaña, Inmaculada, Burgos, Joaquín, Barberà, María José, Arando, Maider, Gutiérrez, F. lix, Masía, Mar, Blanco, José Ramón, Belda-Ibáñez, Josefina, García, Elisa Fernández, Espinosa, Trinidad Zafra, López-Lirola, Ana, Salavert, Miguel, Montero, Marta, Calabuig, Eva, Cuellar, Sandra, Vinciana, Pompeyo, Palacios, Reyes, García, Federico, Peña, Alejandro, Iribarren, José Antonio, Aguado, Mirian, Pulido, Federico, Portillo, Ángel, Gómez-Sirvent, José Luis
Publikováno v:
European journal of public health, 28(3), 451-457. Oxford University Press
Background In Spain, migrants are disproportionately affected by HIV and experience high rates of late diagnosis. We investigated barriers to health care access among migrants living with HIV (MLWH) in Spain. Methods Cross sectional electronic survey
Autor:
Peter Vickerman, Angelos Hatzakis, E. Kafetzopoulos, Natasha K. Martin, Olga Anagnostou, Vana Sypsa, Ilias Gountas
Publikováno v:
Addiction. 112:1290-1299
Aims To project the impact of scaling-up oral anti-viral therapy and harm reduction on chronic hepatitis C (CHC) prevalence and incidence among people who inject drugs (PWID) in Greece, to estimate the relationship between required treatment levels a
Autor:
Richard T Davey, Eduardo Fernández-Cruz, Norman Markowitz, Sarah Pett, Abdel G Babiker, Deborah Wentworth, Surender Khurana, Nicole Engen, Fred Gordin, Mamta K Jain, Virginia Kan, Mark N Polizzotto, Paul Riska, Kiat Ruxrungtham, Zelalem Temesgen, Jens Lundgren, John H Beigel, H Clifford Lane, James D Neaton, Jessica Butts, Eileen Denning, Alain DuChene, Eric Krum, Merrie Harrison, Sue Meger, Ross Peterson, Kien Quan, Megan Shaughnessy, Greg Thompson, David Vock, Julia Metcalf, Robin Dewar, Tauseef Rehman, Ven Natarajan, Rose McConnell, Emily Flowers, Kenny Smith, Marie Hoover, Elizabeth M Coyle, David Munroe, Bitten Aagaard, Mary Pearson, Adam Cursley, Helen Webb, Fleur Hudson, Charlotte Russell, Aminata Sy, Cara Purvis, Brooke Jackson, Yolanda Collaco-Moraes, Dianne Carey, Rosemary Robson, Adriana Sánchez, Elizabeth Finley, Donna Conwell, Marcelo H Losso, Luciana Gambardella, Cecilia Abela, Paco Lopez, Helena Alonso, Giota Touloumi, Vicky Gioukari, Olga Anagnostou, Anchalee Avihingsanon, Kanitta Pussadee, Sasiwimol Ubolyam, Bola Omotosho, Clemencia Solórzano, Tianna Petersen, Kranthi Vysyaraju, Stacey A Rizza, Jennifer A Whitaker, Raquel Nahra, John Baxter, Patricia Coburn, Edward M Gardner, James A Scott, Leslie Faber, Erica Pastor, Linda Makohon, Rodger A MacArthur, L Monique Hillman, Marti J Farrough, Hari M Polenakovik, Linda A Clark, Roberto J Colon, Ken M Kunisaki, Miranda DeConcini, Susan A Johnson, Cameron R Wolfe, Laura Mkumba, June Y Carbonneau, Alison Morris, Meghan E Fitzpatrick, Cathy J Kessinger, Robert A Salata, Karen A Arters, Catherine M Tasi, Ralph J Panos, Laura A Lach, Marshall J Glesby, Kirsis A Ham, Valery G Hughes, Robert T Schooley, Daniel Crouch, Leticia Muttera, Richard M Novak, Susan C Bleasdale, Ariel E Zuckerman, Weerawat Manosuthi, Supeda Thaonyen, Thaniya Chiewcharn, Gompol Suwanpimolkul, Sivaporn Gatechumpol, Sirikunya Bunpasang, Brian J Angus, Monique Anderson, Marcus Morgan, Jane Minton, Maria N Gkamaletsou, Joe Hambleton, David A Price, Martin J Llewelyn, Jonathan Sweetman, Javier Carbone, Jose R Arribas, Rocio Montejano, Jose L Lobo Beristain, Iñaki Z Martinez, Jose Barberan, Paola Hernandez, Dominic E Dwyer, Jen Kok, Alvaro Borges, Christian T Brandt, Lene S Knudsen, Nikolaos Sypsas, Costas Constantinou, Antonios Markogiannakis, Spyros Zakynthinos, Paraskevi Katsaounou, Ioannis Kalomenidis, Analia Mykietiuk, Maria F Alzogaray, Mora Obed, Laura M Macias, Juan Ebensrtejin, Patricia Burgoa, Esteban Nannini, Matias Lahitte, Santiago Perez-Patrigeon, José Arturo Martínez-Orozco, Juan Pablo Ramírez-Hinojosa
Publikováno v:
The Lancet. Respiratory Medicine
INSIGHT FLU-IVIG Study Group 2019, ' Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG) : a double-blind, randomised, placebo-controlled trial ', The Lancet Respiratory Medicine, vol. 7, no. 11, pp. 951-963 . https://doi.org/10.1016/S2213-2600(19)30253-X
INSIGHT FLU-IVIG Study Group 2019, ' Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG) : a double-blind, randomised, placebo-controlled trial ', The Lancet Respiratory Medicine, vol. 7, no. 11, pp. 951-963 . https://doi.org/10.1016/S2213-2600(19)30253-X
Summary Background Since the 1918 influenza pandemic, non-randomised studies and small clinical trials have suggested that convalescent plasma or anti-influenza hyperimmune intravenous immunoglobulin (hIVIG) might have clinical benefit for patients w
Autor:
Olga Anagnostou, Charalampos Karageorgos, Hariklia Kranidioti, Sofia Vasileiadi, Panagiotis Fylaktos, Pinelopi Antonakaki, Melanie Deutsch, Asimina Mpougioukli, Spilios Manolakopoulos
Publikováno v:
Gastroenterology. 160:S-826